K Thielemans

1.5k total citations
24 papers, 1.3k citations indexed

About

K Thielemans is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, K Thielemans has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Immunology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in K Thielemans's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Immunotherapy and Immune Responses (10 papers) and Glycosylation and Glycoproteins Research (7 papers). K Thielemans is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Immunotherapy and Immune Responses (10 papers) and Glycosylation and Glycoproteins Research (7 papers). K Thielemans collaborates with scholars based in Belgium, United States and Germany. K Thielemans's co-authors include Ronald Levy, DG Maloney, RA Miller, James N. Lowder, TC Meeker, William L. Carroll, Jeanette Dilley, Roger A. Warnke, Karine Breckpot and Julie R. Gralow and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Blood.

In The Last Decade

K Thielemans

24 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Thielemans Belgium 14 701 608 395 385 349 24 1.3k
Hákan Mellstedt Sweden 23 637 0.9× 466 0.8× 350 0.9× 355 0.9× 181 0.5× 40 1.2k
Paul V. Beum United States 17 970 1.4× 809 1.3× 322 0.8× 337 0.9× 587 1.7× 29 1.6k
T J Kipps United States 16 700 1.0× 276 0.5× 392 1.0× 314 0.8× 623 1.8× 23 1.4k
JM Pesando United States 9 454 0.6× 469 0.8× 228 0.6× 207 0.5× 284 0.8× 15 996
Kandasamy Hariharan United States 17 467 0.7× 348 0.6× 286 0.7× 292 0.8× 253 0.7× 36 1.1k
Erik Pong United States 16 484 0.7× 617 1.0× 433 1.1× 358 0.9× 97 0.3× 24 1.1k
Michèle Milili France 19 617 0.9× 350 0.6× 341 0.9× 113 0.3× 143 0.4× 35 989
Bernhard Stockmeyer Germany 23 964 1.4× 797 1.3× 465 1.2× 590 1.5× 96 0.3× 35 1.4k
RA Miller United States 7 346 0.5× 476 0.8× 169 0.4× 241 0.6× 245 0.7× 12 792
Robin Pennington United States 10 896 1.3× 242 0.4× 334 0.8× 486 1.3× 85 0.2× 12 1.2k

Countries citing papers authored by K Thielemans

Since Specialization
Citations

This map shows the geographic impact of K Thielemans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Thielemans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Thielemans more than expected).

Fields of papers citing papers by K Thielemans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Thielemans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Thielemans. The network helps show where K Thielemans may publish in the future.

Co-authorship network of co-authors of K Thielemans

This figure shows the co-authorship network connecting the top 25 collaborators of K Thielemans. A scholar is included among the top collaborators of K Thielemans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Thielemans. K Thielemans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frenzel, Katrin, Ludwig Heesen, Stefanie Bolte, et al.. (2017). Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer. Annals of Oncology. 28. xi29–xi29. 2 indexed citations
2.
Breckpot, Karine, Brenda De Keersmaecker, Carlo Heirman, et al.. (2013). Interference with PD-L1/PD-1 co-stimulation during antigen presentation enhances the multifunctionality of antigen-specific T cells. UCL Discovery (University College London). 5 indexed citations
3.
Snauwaert, Sylvia, Sarah Bonte, Glenn Goetgeluk, et al.. (2013). In vitro generation of mature, naive antigen-specific CD8+ T cells with a single T-cell receptor by agonist selection. Leukemia. 28(4). 830–841. 20 indexed citations
4.
Emeagi, Perpetua U., Sarah Maenhout, Nam H. Dang, et al.. (2013). Downregulation of Stat3 in melanoma: reprogramming the immune microenvironment as an anticancer therapeutic strategy. Gene Therapy. 20(11). 1085–1092. 34 indexed citations
5.
Breckpot, Karine, Joeri L. Aerts, & K Thielemans. (2007). Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics. Gene Therapy. 14(11). 847–862. 89 indexed citations
6.
Flamand, Véronique, Sofia Buonocore, Marion Braun, et al.. (2001). Fas deficient dendritic cells transduced with FasL induce strong allogeneic T cell responses in vivo. The FASEB Journal. 15(4). 671–671. 1 indexed citations
7.
Bâkkus, Marleen, Rik Schots, Ivan Van Riet, et al.. (2000). Clonally related IgA‐ and IgE‐secreting plasma cells in a myeloma patient. European Journal Of Haematology. 65(5). 348–355. 11 indexed citations
8.
Strehl, John, Elisabeth Kremmer, Axel Doenecke, et al.. (1999). Induction of tumor immunity by autologous B lymphoma cells expressing a genetically engineered idiotype. Gene Therapy. 6(5). 778–784. 12 indexed citations
9.
Raes, Geert, Jo A. Van Ginderachter, Lea Brys, et al.. (1998). Active antitumor immunotherapy, with or without B7-mediated costimulation, increases tumor progression in an immunogenic murine T cell lymphoma model. Cancer Immunology Immunotherapy. 45(5). 257–265. 14 indexed citations
10.
11.
Juge‐Morineau, Nadine, Carlo Heirman, Marleen Bâkkus, et al.. (1997). Immunoglobulins D and M multiple myeloma variants are heavily mutated.. PubMed. 3(12 Pt 1). 2501–6. 11 indexed citations
12.
Flamand, Véronique, K Thielemans, C. Demanet, et al.. (1993). Vaccination with Tumor Antigen-Pulsed Dendritic Cells Induces in Vivo Resistance to A B Cell Lymphoma. Advances in experimental medicine and biology. 329. 611–616. 18 indexed citations
13.
Heirman, Carlo, et al.. (1992). Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood. 80(9). 2326–2335. 5 indexed citations
14.
Demanet, C., et al.. (1991). Treatment of mice bearing BCL1 lymphoma with bispecific antibodies. The Journal of Immunology. 147(11). 4019–4026. 46 indexed citations
15.
Schots, Rik, et al.. (1991). Southern Blot Analysis in a Case of Richter's Syndrome: Evidence for a Postrearrangement Heavy Chain Gene Deletion Associated with 571 the Altered Phenotype. American Journal of Clinical Pathology. 95(4). 571–577. 22 indexed citations
16.
Heirman, Carlo, et al.. (1990). Isotype switch and idiotype variation in hairy cell leukemia.. PubMed. 4(12). 856–62. 10 indexed citations
17.
Campbell, Michael J., W L Carroll, S Kon, et al.. (1987). Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits.. The Journal of Immunology. 139(8). 2825–2833. 109 indexed citations
18.
Levy, Ronald, T C Meeker, James N. Lowder, et al.. (1986). The immunobiology of B cell lymphoma: clonal heterogeneity as revealed by anti-idiotype antibodies and immunoglobulin gene probes.. PubMed. 38. 261–8. 1 indexed citations
19.
Thielemans, K, Jonathan B. Rothbard, Shoshana Levy, & Ronald Levy. (1985). Syngeneic antiidiotypic immune responses to a B cell lymphoma. Comparison between heavy chain hypervariable region peptides and intact Ig as immunogens.. The Journal of Experimental Medicine. 162(1). 19–34. 20 indexed citations
20.
Sklar, Jeffrey, Michael L. Cleary, K Thielemans, et al.. (1984). Biclonal B-Cell Lymphoma. New England Journal of Medicine. 311(1). 20–27. 181 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hákan Mellstedt Breakdown of academic impact, for papers by Paul V. Beum Breakdown of academic impact, for papers by T J Kipps Breakdown of academic impact, for papers by JM Pesando Breakdown of academic impact, for papers by Kandasamy Hariharan Breakdown of academic impact, for papers by Erik Pong Breakdown of academic impact, for papers by Michèle Milili Breakdown of academic impact, for papers by Bernhard Stockmeyer Breakdown of academic impact, for papers by RA Miller Breakdown of academic impact, for papers by Robin Pennington
Rankless by CCL
2026